A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease
AD individuals in the Netherlands exhibit a significantly higher prevalence of polypharmacy in a year pre-AD diagnosis. The findings highlight the complexity of managing multiple comorbid conditions in AD individuals, emphasizing the need for regular review and optimization of medication regimens and the inclusion of non-pharmacological interventions to minimize adverse outcomes and improve quality of life.
Authors
- Stijn de Vos (ORCID: https://orcid.org/0000-0001-6965-4959)
- Sumaira Mubarik (ORCID: https://orcid.org/0000-0001-6041-1061)
- Barbara C. Van Munster (ORCID: https://orcid.org/0000-0001-6056-7795)
- Catharina C. M. Schuiling‐Veninga (ORCID: https://orcid.org/0000-0002-8527-2608)
- Eelko Hak (ORCID: https://orcid.org/0000-0003-0849-7210)
- Hendrika J. Luijendijk (ORCID: https://orcid.org/0000-0002-6865-0128)
- Jens Bos (ORCID: https://orcid.org/0000-0001-9209-7564)
- Ali Alghamdi (ORCID: https://orcid.org/0009-0002-6780-8947)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1177/13872877241305799
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.22
Funders
- Rijksuniversiteit Groningen